Healthy Living

Medication Puts Elderly Lymphoma Patients at Risk for Shortened Survival

Taking geriatric factors into account

As Dr. Diefenbacher said, “it’s important to identify and tease out geriatric-related issues that are potentially correctable to improve the outcomes of patients and to increase the number of elderly patients who could possibly be treated with high-dose curative intent therapy.”

The researchers examined 171 patients, on average seventy years of age, with non-Hodgkin lymphoma, who were treated between 2009 and 2014. This took place at two different hospitals, and treatment lasted, on average, twenty eight months. They looked over their prescribed medications and any ill results the medications may have caused.

Between two and seven, most often four, medications were prescribed to each patient as part of the curative-intent treatment. Of these patients, 47% ended up being prescribed at least one medication that was on the 2015 Beers Criteria list.